Black Friday in July — Save up to $3,600 on Clearlight + a free lounge chair. Ends July 31

HSA/FSA Eligible— Your wellness purchase may qualify. Save up to 35% with pre-tax dollars. Learn More →

Summer Wellness Sale · Now–July 31 · Save up to $1,000 plus exclusive promos on every product, every brand — tap Get Pricing for your best price

Authorized Dealer for 15+ Premium Wellness Brands

Talk to a Specialist

Call, text, or live chat

7 Days a Week | 9AM–5PM EST
Get Pricing

630nm Photobiomodulation by low-power laser irradiation attenuates Aβ-induced cell apoptosis through the Akt/GSK3β/β-catenin pathway

630nm Photobiomodulation by low-power laser irradiation attenuates Aβ-induced cell apoptosis through the Akt/GSK3β/β-catenin pathway

Study Overview

  • Description: This study reports a novel molecular mechanism by which low-power laser irradiation (LPLI) attenuates amyloid β peptide (Aβ)-induced cell apoptosis through the Akt/GSK3β/β-catenin pathway.
  • Source: PubMed

Summary

  • Background: Apoptosis induced by amyloid β peptide (Aβ) is thought to be associated with the pathogenesis of Alzheimer disease (AD). LPLI is known to reduce Aβ-induced apoptosis, but the underlying mechanisms were unclear.
  • Findings/Mechanism: The study revealed a novel molecular mechanism:
  • LPLI activated Akt.
  • The activated Akt interacted with GSK3β and phosphorylated it on Ser9 in the presence of Aβ(25-35), resulting in the inhibition of GSK3β's activity.
  • LPLI, via the Akt/GSK3β pathway, increased the nuclear translocation of β-catenin and enhanced its transcriptional activity to promote cell survival.
  • Conclusion: The data demonstrate that LPLI has a pro-survival effect on Aβ-induced apoptosis and may be an effective therapeutic strategy in treating Alzheimer's disease (AD) by targeting GSK3β.

Leave a comment